Explore FHI 360

7 Results Found

  • Published research
    Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial
    The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.
  • Published research
    Using behavior change approaches to improve complementary feeding practices
    Improving complementary feeding of children 6 to 24 months of age requires an understanding of what drives feeding behaviors in specific cultural and economic contexts and which systematic approaches best facilitate beneficial and feasible changes. This paper analyzes social and behavior change approaches and use of program delivery platforms at scale that resulted in documented improvements in Bangladesh, Malawi, Peru and Zambia. The authors conclude that complementary feeding practices, particularly dietary diversity, can be improved rapidly in a variety of settings through available program platforms if interventions focus on specific constraints and strategies encourage caregivers to prepare and feed appropriate foods.
  • News
    The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) named FHI 360 a winner of the DREAMS Innovation Challenge for the Communities Investing in Education for Child Health and Safety project.
  • Project
    The Africa DREAMS: Malawi Communities Investing in Education for Child Health and Safety (CIECHS) project focuses on gender and education as critical ways to reduce the incidence of HIV. CIECHS is funded by the DREAMS Innovation Challenge.
  • Past Project
    Injectable contraceptives are among the most popular family planning options. They are safe, effective and discreet. But, in many countries, they are not widely available outside clinic settings. 
  • Project
    FHI 360 provides support to the U.S. National Institutes of Health, Division of AIDS (DAIDS) clinical research community through the HIV Clinical Research Support Services (CRSS) project.
  • Past Project
    FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.